
Arcutis (ARQT) Director Sells $121K Amid 65% Revenue Jump
Arcutis Biotherapeutics director Sue-Jean Lin sold $121,000 in stock under a prearranged plan, even as ZORYVE revenue surged 65% year over year. Here's what the numbers and the commercial trajectory…





